Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by hmmmmmmmmon May 13, 2023 2:49pm
116 Views
Post# 35447009

RE:RE:RE:Ok let’s say they get to 90…

RE:RE:RE:Ok let’s say they get to 90…Maybe these are the incredible achievements that justify Seto being paid 901k and recieving millions of options for 2022?

From Spectral's announcements it seems they added 15 patients in 2022.

Spectral lost control of DIMI and SAMI in 2022.

They hired Sam Amory as President of Dialco for a few months- a company they then said they couldn't raise money for.. chocking up a Massive severance payout.

On March 8 2021 when Seto was announced as CEO the SP was at .57- that is the highest we've seen the stock close at since..
<< Previous
Bullboard Posts
Next >>